Home Cart 0 Sign in  

[ CAS No. 4298-08-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 4298-08-2
Chemical Structure| 4298-08-2
Structure of 4298-08-2 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 4298-08-2 ]

Related Doc. of [ 4298-08-2 ]

Alternatived Products of [ 4298-08-2 ]

Product Details of [ 4298-08-2 ]

CAS No. :4298-08-2 MDL No. :MFCD00216471
Formula : C5H9NO3 Boiling Point : -
Linear Structure Formula :- InChI Key :BJBUEDPLEOHJGE-IMJSIDKUSA-N
M.W : 131.13 Pubchem ID :440575
Synonyms :

Safety of [ 4298-08-2 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 4298-08-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 4298-08-2 ]
  • Downstream synthetic route of [ 4298-08-2 ]

[ 4298-08-2 ] Synthesis Path-Upstream   1~7

  • 1
  • [ 4298-08-2 ]
  • [ 130966-46-0 ]
Reference: [1] Journal of Medicinal Chemistry, 2007, vol. 50, # 13, p. 3015 - 3025
[2] Organic Letters, 2001, vol. 3, # 16, p. 2481 - 2484
  • 2
  • [ 24424-99-5 ]
  • [ 4298-08-2 ]
  • [ 187039-57-2 ]
YieldReaction ConditionsOperation in experiment
91%
Stage #1: With sodium hydrogencarbonate In tetrahydrofuran; water at 0 - 20℃;
Stage #2: With hydrogenchloride In dichloromethane; water
Method A: To a stirred solution of the carboxylic acid (20.3 mmol) in tetrahydrofuran (75 ml) was added di-tert-butyl dicarbonate (2.5 equivalents (eq.), 50.8 mmol) followed by the addition of sodium bicarbonate (6 eq., 122 mmol) in water (75 ml). The carboxylic acids are commercially available from vendors like Aldrich, Acros, Anaspec, CNH technologies, etc. The addition is typically carried out at low temperatures, e.g. 0° C., after which the reaction was brought to rt and let to stir for 16 h. The reaction was concentrated to remove all solvent, diluted with excess water and extracted with ether. The aqueous layer was acidified with 6N HCl and extracted with DCM (2.x.) and once with n-butanol. All organic extracts were combined, concentrated, and co-evaporated with toluene. The residue was then dried under high vacuum to give the desired Boc-protected carboxylic acid.Step 1:
(2S,3S)-1-(tert-Butoxycarbonyl)-3-hydroxypyrrolidine-2-carboxylic acid was prepared from (2S,3S)-3-Hydroxypyrrolidine-2-carboxylic acid following Method A (yield=91percent).
The resulting product was used without purification. 1H NMR (DMSO-d6): 5.64-5.63 (d, 1H), 4.42 (bs, 1H), 4.13-4.10 (d, 1H), 3.64-3.48 (m, 2H), 2.11-1.99 (m, 2H), 1.58-1.52 (d, 9H). HPLC: Rt=3.868 min following Method R. ES-MS: calcd. for C10H17NO5 (231.25); found: 230.2 [M-H].
90% With sodium hydrogencarbonate In 1,4-dioxane; water at 20℃; Trans-3-hydroxy-L-proline (2.62 g, 20.0 mmol) and sodium bicarbonate (5.04 <n="132"/>g, 60 mmol) were dissolved in water (20 ml). Dioxane was added (20 ml) followed by di- tert-butyl-dicarbonate (8.72 g, 40 mmol). Stirring was continued at room temperature overnight. The reaction was concentrated, and the residue was partitioned between ethyl ether (10 ml) and water (30 ml). The aqueous layer was washed once more with ether, and the organic layers were discarded. Gradual acidification of the aqueous phase with concentrated HCl caused the oily product to precipitate and this was extracted into ethyl acetate by repeated washings (3x10 ml) of the aqueous layer. The combined organic layers were washed with brine, dried (MgSO4) and concentrated to provide the title compound as a viscous oil (4.17 g, 90percent).
90% With N-ethyl-N,N-diisopropylamine In methanol at 20℃; for 2 h; Preparation 8; (2S,3S)- 1 -(tert-butoxycarbonyl)-3 -hydroxypyrrolidine-2-carboxylic acid; A suspension of .pound.rαroe-3-hydroxy-L-proline (5 g, 37.56 mmol) in methanol (100 mL) is treated with diisopropylethylamine (6.55 mL, 37.56 mmol) and subsequently di-t- butyldicarbonate (8.87 g, 39.44 mmol) at room temperature. The resulting suspension is stirred for 2 h at room temperature while becoming a homogeneous solution. The solvent is removed in vacuo and the residue is dissolved in ethyl acetate (120 mL). The organic solution is washed with 1 N aqueous hydrogen chloride. The aqueous layer is discarded and the organic layer is washed with brine, dried over sodium sulfate, concentrated, and dried under vacuum to give 8.0 g (90percent) of the title compound. 1H NMR (300 MHz, CDCl3) δ 12.60 (s, br, IH), 5.40 (s, br, IH), 4.20-4.12 (m, IH), 3.87 (d, J = 6.4 Hz, IH), 3.25-3.42 (m, 2H), 1.90-1.75 (s, br, IH), 1.74-1.65 (s, br, IH), 1.30 (d, J = 7.1 Hz, 9H).
85% With sodium carbonate In 1,4-dioxane; water at 20℃; for 1.5 h; Boc anhydride (2.95 g, 13.5 mmol) was added to a stirred solution of the (2S, 3S)-3-HYDROXYPYRROLIDINE-2-CARBOXYLIC acid (1.61 g, 12.3 mmol) and sodium carbonate (1.3 g, 12.3 mmol) in a mixture of dioxane (25 ml) and water (12.3 ml). The mixture was stirred for 1.5 h at ambient temperature then evaporated under reduced pressure to afford a residue (-10 ml). The residue was diluted with water (30 ML) then extracted with ethyl acetate (40 ml). The aqueous phase was acidified (PH-2. 5) with dilute aqueous hydrochloric acid (0.1 M) then extracted with chloroform (4 x 50 ml). The combined organic layers were dried (NA2SO4) and evaporated under reduced pressure to afford (2S, 3S)-3-hydroxypyrrolidine-1, 2-dicarboxylic acid 1-TERT-BUTYL ester as a white crystalline solid (2.39 G,-85percent), HPLC- MS (single main peak, 254.1 [M + Na] + and 485.2 [M + H] +).
70% With sodium hydroxide In tetrahydrofuran; water EXAMPLE 18A
(2S,3 S)-1-(tert-butoxycarbonyl)-3-hydroxy-2-pyrrolidinecarboxylic acid
trans-3-Hydroxy (L)-proline (10.0 g, 76.3 mmol) in THF (50 mL) was treated with sodium hydroxide (3.36 g, 84 mmol) in water (34 mL) at ambient temperature.
After 10 minutes of stirring, the mixture was treated with di-tert-butyl dicarbonate (16.63 g, 76.3 mmol) portionwise.
After stirring at ambient temperature for 10 hours, the mixture was concentrated under reduced pressure, acidified to pH 2-3 with saturated KHSO4 (aq), and extracted with ethyl acetate (2*200 mL).
The organic extracts were combined, washed with brine (2*30 mL), and concentrated to provide the title compound as a white solid (12.3 g, 70percent, yield).
mp 156-157° C.
70%
Stage #1: With sodium hydroxide In tetrahydrofuran; water
Stage #2: at 20℃; for 10 h;
Stage #3: With CHO4(1-)*K(1+) In water
trans-3-Hydroxy-(L)-proline (10.0 g, 76.3 mmol) in THF (50 mL) was treated with sodium hydroxide (3.36 g, 84 mmol) in H2O (34 mL) and then treated with di-tert-butyl dicarbonate (16.63 g, 76.3 mmol) portionwise. After stirring at ambient temperature for 10 hours, the mixture was concentrated under reduced pressure to remove the THF. The residue was acidified to pH 2-3 with saturated KHSO4 and extracted with ethyl acetate (2 x 200 mL). The organic extracts were combined, washed with brine (2 x 30 mL) and concentrated to provide the title compound as a white solid (12.3 g, 70percent). mp 156-157 °C.
0.91 g With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; To a solution of (2S,3S)-3-hydroxypyrrolidine-2-carboxylic acid (0.50 g, 3.8 mmol) in CH2Cl2 (19 mL) at roomtemperature was added di-tert-butyl dicarbonate (0.96 mL, 4.2 mmol) and Hunig’s base (1.32 mL, 7.6 mmol) to give atan solution. The reaction was stirred overnight at room temperature and then diluted with CH2Cl2 and washed withsaturated sodium bicarbonate solution. The aqueous layer was concentrated under reduced pressure and then suspendedin methanol and filtered. The solvent was then removed under reduced pressure to prodive the title compound(0.91g, 103percent yield).

Reference: [1] Journal of Medicinal Chemistry, 2006, vol. 49, # 21, p. 6254 - 6263
[2] Tetrahedron Letters, 2009, vol. 50, # 52, p. 7280 - 7282
[3] Tetrahedron Letters, 1997, vol. 38, # 2, p. 167 - 168
[4] Patent: US2010/22605, 2010, A1, . Location in patent: Page/Page column 16; 33; 36
[5] Patent: WO2008/24725, 2008, A1, . Location in patent: Page/Page column 130-131
[6] Patent: WO2009/140448, 2009, A1, . Location in patent: Page/Page column 32
[7] Patent: WO2004/7501, 2004, A1, . Location in patent: Page 504-505
[8] Journal of the American Chemical Society, 2005, vol. 127, # 45, p. 15923 - 15932
[9] Patent: US2002/19388, 2002, A1,
[10] Patent: EP1428824, 2004, A1, . Location in patent: Page 50
[11] Tetrahedron Letters, 2001, vol. 42, # 4, p. 651 - 653
[12] Patent: US2005/209217, 2005, A1, . Location in patent: Page/Page column 27
[13] European Journal of Organic Chemistry, 2009, # 20, p. 3368 - 3386
[14] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 23, p. 5478 - 5483
[15] Patent: EP2419404, 2015, B1, . Location in patent: Paragraph 0504
[16] Patent: WO2016/25669, 2016, A1, . Location in patent: Page/Page column 72
[17] Patent: WO2017/63757, 2017, A1, . Location in patent: Page/Page column 45
  • 3
  • [ 58632-95-4 ]
  • [ 4298-08-2 ]
  • [ 187039-57-2 ]
Reference: [1] Organic Letters, 2001, vol. 3, # 16, p. 2481 - 2484
[2] Patent: US6900238, 2005, B1, . Location in patent: Page/Page column 51
  • 4
  • [ 34619-03-9 ]
  • [ 4298-08-2 ]
  • [ 187039-57-2 ]
Reference: [1] European Journal of Organic Chemistry, 2014, vol. 2014, # 24, p. 5351 - 5355
  • 5
  • [ 24424-99-5 ]
  • [ 4298-08-2 ]
  • [ 7087-68-5 ]
  • [ 187039-57-2 ]
Reference: [1] Patent: US2010/267634, 2010, A1,
  • 6
  • [ 4298-08-2 ]
  • [ 184046-78-4 ]
Reference: [1] Journal of Medicinal Chemistry, 2007, vol. 50, # 13, p. 3015 - 3025
[2] Journal of the American Chemical Society, 2005, vol. 127, # 45, p. 15923 - 15932
[3] Organic Letters, 2001, vol. 3, # 16, p. 2481 - 2484
[4] Tetrahedron Letters, 2001, vol. 42, # 4, p. 651 - 653
[5] RSC Advances, 2013, vol. 3, # 42, p. 19533 - 19544
[6] Patent: WO2014/165075, 2014, A1,
[7] ChemMedChem, 2017, vol. 12, # 20, p. 1687 - 1692
[8] Patent: WO2009/137130, 2009, A2,
[9] Patent: WO2005/121135, 2005, A1,
[10] Patent: WO2005/32468, 2005, A2,
  • 7
  • [ 67-56-1 ]
  • [ 24424-99-5 ]
  • [ 4298-08-2 ]
  • [ 184046-78-4 ]
Reference: [1] Angewandte Chemie - International Edition, 2017, vol. 56, # 14, p. 4011 - 4014[2] Angew. Chem., 2017, vol. 129, # 14, p. 4069 - 4072,4
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 4298-08-2 ]

Amino Acid Derivatives

Chemical Structure| 2584-71-6

[ 2584-71-6 ]

H-D-cis-Hyp-OH

Similarity: 0.95

Chemical Structure| 618-27-9

[ 618-27-9 ]

(2S,4S)-4-Hydroxypyrrolidine-2-carboxylic acid

Similarity: 0.95

Chemical Structure| 51-35-4

[ 51-35-4 ]

(2S,4R)-4-Hydroxypyrrolidine-2-carboxylic acid

Similarity: 0.95

Chemical Structure| 3398-22-9

[ 3398-22-9 ]

(2R,4S)-4-Hydroxypyrrolidine-2-carboxylic acid

Similarity: 0.95

Chemical Structure| 77449-94-6

[ 77449-94-6 ]

(2R,4R)-4-Hydroxypyrrolidine-2-carboxylic acid hydrochloride

Similarity: 0.93